Dr. Venkatesh Babu G. Segu's Credentials
Accepting New Patients
Yes, this doctor is accepting new patients
Dr. Venkatesh Segu has over 17 years of clinical experience in Endocrinology, Diabetes, and Internal Medicine. He has been formally trained in both the U.S. and India and has actively contributed to a variety of research publications. He is passionate about dedicating time to patients so they can get the best medical care possible. Board Certification in Endocrinology, Internal Medicine, and Metabolism 17+ years of clinical practice in Texas, Indiana, and Utah Research Fellowship at the Pacific Northwest Research Institute Senior Endocrine Fellowship at the University of Washington Medical School Endocrine Fellowship at the University of Wisconsin Thyroid Ultrasound and Biopsy Certification by the American College of Endocrinology
- University of Washington (Grad. 2001)
- University of Wisconsin (Grad. 1999)
- Mysore Medical College (Grad. 1989)
- Postgraduate Institute of Medical Education and Research (Grad. 1995)
Areas of Expertise
- Type 2 diabetes
- Thyroid nodules
- Polycystic ovary syndrome (PCOS)
- Type 1 diabetes
- Hypothyroidism (underactive thyroid)
- Hyperthyroidism (overactive thyroid)
- Thyroid cancer
- Male hypogonadism
- Pituitary tumors
- Addison's disease
- Cushing syndrome
- Postpartum thyroiditis
- Hashimoto's disease
- Congenital adrenal hyperplasia
Awards & Recognitions
Publications & Research
- What is the diagnosis? Gastrointestinal duplication cyst.
- Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis.
- Use of a soluble tetrazolium compound to assay metabolic activation of intact beta cells.
- Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose- and calcium-induced insulin secretion from pancreatic beta cells.
- Use of In-111 pentetreotide scintigraphy in the diagnosis of a midgut carcinoid causing Cushing's syndrome.
- Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
- Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids.